Publications
Original Articles
Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune response
Cancer Vaccines
2024
Authors:
John B Liao, James Y Dai, Jessica L Reichow, Jong-Baeck Lim, Katie M Hitchcock-Bernhardt, Sasha E Stanton, Lupe G Salazar, Theodore A Gooley, Mary L Disis
Journal:
Journal for Immunotherapy of Cancer
Volume:
12(11)
Page:
e010251
Original Article
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer
Cancer Vaccines
2022
Authors:
Cecil, D.L., Curtis, B, Gad, E., Gormley, M, Timms, A.E., Corulli, L., Bos, R., Damle, R.N., Sepulveda, M.A., and Disis, M.L.
Journal:
Scientific Reports
Volume:
12
Page:
13618
Original Article
COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes
Cancer Vaccines
2022
Authors:
Cecil DL, Gad EA, Corulli LR, Drovetto N, Lubet RA, Disis ML
Journal:
Cancer Prevention Research
Volume:
15(4)
Page:
225-231
Original Article
Unexpected Liver and Kidney Pathology in C57BL/6J Mice Fed a High-fat Diet and Given Azoxymethane to Induce Colon Cancer
Cancer Vaccines
2022
Authors:
Waggie, KS, Corulli, LR, Cecil, D, Rodmaker, ER, Walsh, C, and Disis, ML
Journal:
Comparative Medicine
Volume:
72(5)
Page:
330-335
Review Article
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Cancer Vaccines
2021
Authors:
Antonarelli G, Corti C, Tarantino P, Ascione L, Cortes J, Romero P, Mittendorf EA, Disis ML, Curigliano G
Journal:
Annals of Oncology
Volume:
32(12)
Page:
1537-1551
Original Article
Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention
Cancer Vaccines
2021
Authors:
Corulli LR, Cecil DL, Gad E, Koehnlein M, Coveler AL, Childs JS, Lubet RA, Disis ML.
Journal:
Frontiers in Immunology
Volume:
12
Page:
Review Article
Vaccine Therapies for Cancer: Then and Now
Cancer Vaccines
2021
Authors:
Morse, MA, Gwin, WR 3rd, and Mitchell, DA
Journal:
Targeted Oncology
Volume:
16(2)
Page:
121-152
Original Article
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways
Cancer Vaccines
2021
Authors:
Cecil, D., Park, K H, Curtis, B, Corulli, L, and Disis, ML
Journal:
Journal for Immunotherapy of Cancer
Volume:
9
Page:
Original Article
Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets
Cancer Vaccines
2019
Authors:
Stanton SE, Gad E, Corulli LR, Lu H, Disis ML.
Journal:
Vaccine
Volume:
37(27)
Page:
3552-3561
Review Article
Next generation approaches for tumor vaccination
Cancer Vaccines
2017
Authors:
Patel A, Kaufman HL, Disis ML.
Journal:
Chinese Clinical Oncology
Volume:
6(2)
Page:
19